SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS — Credit Rating and Financial Key Figures
CVR number: 32155014
Klosterstræde 2, 5700 Svendborg
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 3 372.19 | 3 573.88 | 3 520.06 | 3 979.68 | 4 023.95 |
| Purchases during the financial year | -15.32 | -34.23 | -14.20 | -25.28 | -22.52 |
| External services | - 572.81 | - 572.28 | - 601.74 | - 625.21 | - 706.77 |
| Gross profit | 2 784.06 | 2 967.36 | 2 904.13 | 3 329.19 | 3 294.67 |
| Wages and salaries | -2 335.87 | -2 587.72 | -2 524.44 | ||
| Social security expenses | - 247.63 | - 285.04 | - 289.30 | ||
| Employee benefit expenses | -3 102.72 | -3 101.74 | |||
| Total depreciation | -87.17 | -78.16 | -87.15 | -61.27 | -48.62 |
| EBIT | 113.39 | 16.44 | 3.24 | 165.20 | 144.31 |
| Other financial income | 51.38 | 152.22 | 3.49 | 75.25 | 31.07 |
| Other financial expenses | -2.32 | -4.52 | -47.43 | -21.49 | -25.01 |
| Pre-tax profit | 162.45 | 164.14 | -40.70 | 218.96 | 150.37 |
| Income taxes | -35.80 | -36.17 | 8.88 | -48.14 | -33.18 |
| Net earnings | 126.65 | 127.97 | -31.82 | 170.83 | 117.18 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Goodwill | 0.00 | 0.00 | |||
| Intangible assets total | 0.00 | 0.00 | |||
| Machinery and equipment | 253.55 | 175.39 | 154.80 | 93.54 | 124.97 |
| Tangible assets total | 253.55 | 175.39 | 154.80 | 93.54 | 124.97 |
| Other receivables | 14.98 | 15.43 | |||
| Investments total | 14.98 | 15.43 | |||
| Long term receivables total | |||||
| Raw materials and consumables | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Inventories total | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Current trade debtors | 230.00 | 250.00 | 250.00 | 250.00 | 250.00 |
| Prepayments and accrued income | 17.57 | 10.71 | 12.29 | 10.97 | 11.43 |
| Current other receivables | 13.45 | 13.85 | 14.75 | ||
| Current deferred tax assets | 2.81 | 1.12 | 18.77 | 0.14 | 0.55 |
| Short term receivables total | 263.82 | 275.68 | 295.80 | 261.11 | 261.98 |
| Other current investments | 390.14 | 332.60 | 298.39 | 368.49 | 390.62 |
| Cash and bank deposits | 112.46 | 534.00 | 470.48 | ||
| Cash and cash equivalents | 502.61 | 332.60 | 298.39 | 902.49 | 861.10 |
| Balance sheet total (assets) | 1 020.98 | 784.66 | 749.99 | 1 273.12 | 1 264.47 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 110.60 | 113.00 | 114.40 | 117.80 | 135.00 |
| Retained earnings | 8.11 | 21.76 | 35.33 | - 114.29 | -78.46 |
| Profit of the financial year | 126.65 | 127.97 | -31.82 | 170.83 | 117.18 |
| Shareholders equity total | 370.36 | 387.73 | 242.91 | 299.34 | 298.72 |
| Provisions | 24.35 | 14.47 | 5.58 | ||
| Non-current liabilities total | |||||
| Current loans from credit institutions | 63.37 | 79.52 | |||
| Current owed to participating | 723.11 | 835.68 | |||
| Short-term deferred tax liabilities | 27.73 | 32.05 | 32.75 | 19.68 | |
| Other non-interest bearing current liabilities | 598.54 | 287.05 | 421.98 | 217.91 | 110.39 |
| Current liabilities total | 626.27 | 382.47 | 501.49 | 973.78 | 965.75 |
| Balance sheet total (liabilities) | 1 020.98 | 784.66 | 749.99 | 1 273.12 | 1 264.47 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.